ArticleCritical care (London, England)2022

Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study.

Khalid Al Sulaiman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.